Login
$KOD
$101.46 +$0.73 (0.73%) After hours

Company Executives

Officer Age Joined 2025 pay Source
Victor Perlroth Also a director
Chief Executive Officer and Chairman of the Board
53 Not stated $2,499,221
John A. Borgeson
Executive Vice President, Chief Financial Officer and Secretary
64 2016 $1,615,857

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Average tenure
9.3 years
from year joined
CEO also chairs the board
Yes
Victor Perlroth, M.D.
Director Age On board Committees Other public boards 2025 pay Source
Victor Perlroth, M.D.
53 2009
17 years
None stated None stated Paid as CEO
Robert A. Profusek, J.D.
76 2018
8 years
Nominating and Governance · Chair
CTS Corporation $179,300
Charles A. Bancroft
66 2020
6 years
None stated GSK plc $170,300
Bassil I. Dahiyat, Ph.D.
55 2018
8 years
Audit
Xencor, Inc. $147,800
Taiyin Yang, Ph.D.
72 2019
7 years
Audit
Brii Biosciences Limited $147,800
Felix J. Baker, Ph.D.
57 2015
11 years
Compensation · Chair
Kiniksa Pharmaceuticals International, plc. $92,800
Richard S. Levy, M.D.
68 2018
8 years
Nominating and Governance
Kiniksa Pharmaceuticals, Ltd. $142,800

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 22, 2026
each of our directors and certain of our officers
directors and certain officers
Amount not stated

Separate indemnification agreements entered into with each director and certain officers.

our named executive officers, other executive officers and our non-employee directors
named executive officers, other executive officers and non-employee directors
Amount not stated

Grants of stock options and RSUs to named executive officers, other executive officers and non-employee directors.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support